Chengxiao Liao
Overview
Explore the profile of Chengxiao Liao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Y, Chen L, Zou Y, Yu H, Xie W, Gan Q, et al.
Heliyon
. 2024 Jun;
10(11):e31587.
PMID: 38841471
Aims: To provide a comprehensive bibliometric overview of drug resistance in bladder cancer (BC) from 1999 to 2022, aiming to illuminate its historical progression and guide future investigative avenues. Methods:...
2.
Wu S, Shen R, Hong G, Luo Y, Wan H, Feng J, et al.
EClinicalMedicine
. 2024 Apr;
71:102566.
PMID: 38686219
Background: Urine cytology is an important non-invasive examination for urothelial carcinoma (UC) diagnosis and follow-up. We aimed to explore whether artificial intelligence (AI) can enhance the sensitivity of urine cytology...
3.
Wu S, Wang Y, Hong G, Luo Y, Lin Z, Shen R, et al.
EClinicalMedicine
. 2024 Apr;
71:102580.
PMID: 38618206
Background: The pathological examination of lymph node metastasis (LNM) is crucial for treating prostate cancer (PCa). However, the limitations with naked-eye detection and pathologist workload contribute to a high missed-diagnosis...
4.
Huang Y, Liu L, Gan Q, Shen Z, Yao Y, Liao C, et al.
Heliyon
. 2024 Apr;
10(7):e28160.
PMID: 38571632
Background: The prognostic significance of tumor size with adrenocortical carcinoma (ACC) patients has not yet been thoroughly evaluated. Our objective was to investigate the influence of tumor size on prognostic...
5.
Huang Y, Liao C, Shen Z, Zou Y, Xie W, Gan Q, et al.
Front Immunol
. 2024 Mar;
15:1297542.
PMID: 38444854
Background: Neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) remains the cornerstone of treatment for muscle-invasive bladder cancer (MIBC). While platinum-based regimens have demonstrated benefits in tumor downstaging and improved...
6.
Huang Y, Chen Z, Shen G, Fang S, Zheng J, Chi Z, et al.
Hum Vaccin Immunother
. 2024 Feb;
20(1):2318815.
PMID: 38419524
This study aims to conduct a bibliometric analysis, employing visualization tools to examine literature pertaining to tumor immune evasion related to anti-CTLA-4 and anti-PD-1/PD-L1 therapy from 1999 to 2022. A...
7.
Wu S, Hong G, Xu A, Zeng H, Chen X, Wang Y, et al.
Lancet Oncol
. 2023 Mar;
24(4):360-370.
PMID: 36893772
Background: Accurate lymph node staging is important for the diagnosis and treatment of patients with bladder cancer. We aimed to develop a lymph node metastases diagnostic model (LNMDM) on whole...
8.
Pan J, Hong G, Zeng H, Liao C, Li H, Yao Y, et al.
J Transl Med
. 2023 Jan;
21(1):42.
PMID: 36691055
Background: Accurate pathological diagnosis of invasion depth and histologic grade is key for clinical management in patients with bladder cancer (BCa), but it is labour-intensive, experience-dependent and subject to interobserver...